XML 28 R16.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-Based Compensation and Other Employee Benefit Plans
6 Months Ended
Jun. 30, 2019
Share-based Compensation [Abstract]  
Stock-Based Compensation and Other Employee Benefit Plans
Note 9Stock-Based Compensation and Other Employee Benefit Plans
The Company has stock-based compensation plans, under which shares of the Company’s common stock are reserved for issuance. Under all stock-based compensation plans in effect as of June 30, 2019, including employee stock purchase plans, there were approximately 4,144,000 shares available for future grant.
Non-cash stock-based compensation expense under all plans totaled $4.2 million and $3.4 million for the three month periods ended June 30, 2019 and 2018, respectively, and totaled $7.9 million and $6.6 million for the six month periods ended June 30, 2019 and 2018, respectively. Income tax benefits associated with stock-based compensation arrangements totaled $1.1 million and $1.0 million for the three month periods ended June 30, 2019 and 2018, respectively. For the six month periods ended June 30, 2019 and 2018 income tax benefits totaled $4.2 million and $1.8 million, respectively, including net tax benefits from the vesting of share-based payment awards of $2.3 million and $0.2 million, respectively.
Restricted Shares
MasTec grants restricted stock awards and restricted stock units (together, “restricted shares”) to eligible participants, which are valued based on the closing market share price of MasTec common stock (the “market price”) on the date of grant. During the restriction period, holders of restricted stock awards are entitled to vote the shares. Total unearned compensation related to restricted shares as of June 30, 2019 was approximately $27.5 million, which is expected to be recognized over a weighted average period of approximately 2.2 years. The intrinsic value of restricted shares that vested, which is based on the market price on the date of vesting, totaled $0.3 million and $1.6 million for the three month periods ended June 30, 2019 and 2018, respectively, and totaled $13.9 million and $1.7 million for the six month periods ended June 30, 2019 and 2018, respectively.
Activity, restricted shares: (a)
Restricted
Shares
 
Per Share Weighted Average Grant Date Fair Value
Non-vested restricted shares, as of December 31, 2018
1,270,233

 
$
31.80

Granted
223,969

 
46.91

Vested
(331,959
)
 
13.73

Canceled/forfeited
(5,650
)
 
33.28

Non-vested restricted shares, as of June 30, 2019
1,156,593

 
$
39.90


(a)
Includes 3,600 and 18,700 restricted stock units as of June 30, 2019 and December 31, 2018, respectively.

Employee Stock Purchase Plans
The Company has certain employee stock purchase plans (collectively, “ESPPs”) under which shares of the Company's common stock are available for purchase by eligible employees. The following table provides details pertaining to the Company’s ESPPs for the periods indicated:
 
For the Six Months Ended June 30,
 
2019
 
2018
Cash proceeds (in millions)
$
2.4

 
$
2.2

Common shares issued
63,976

 
55,138

Weighted average price per share
$
37.52

 
$
39.99

Weighted average per share grant date fair value
$
9.54

 
$
9.74